Cargando…
A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis
PURPOSE: Cisplatin resistance is the major obstacle in the clinical treatment of ovarian cancer patients. Molecular mechanisms of cisplatin resistance are multifaceted. Gold(I)-compounds, i.e. N-heterocyclic carbene-gold(I)-complexes (NHC-Au(I)) has been regarded as promising cytotoxic drug candidat...
Autores principales: | König, Philipp, Zhulenko, Roman, Suparman, Eloy, Hoffmeister, Henrik, Bückreiß, Nico, Ott, Ingo, Bendas, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261188/ https://www.ncbi.nlm.nih.gov/pubmed/37272932 http://dx.doi.org/10.1007/s00280-023-04548-1 |
Ejemplares similares
-
The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
por: Hassan, Nourhan, et al.
Publicado: (2023) -
Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway
por: Pfankuchen, Daniel Bastian, et al.
Publicado: (2017) -
Activation of a Copper Biscarbene Mechano‐Catalyst Using Single‐Molecule Force Spectroscopy Supported by Quantum Chemical Calculations
por: Sammon, Matthew S., et al.
Publicado: (2021) -
ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics
por: Levidou, Georgia, et al.
Publicado: (2012) -
A NANOG‐pERK reciprocal regulatory circuit regulates Nanog autoregulation and ERK signaling dynamics
por: Kale, Hanuman T, et al.
Publicado: (2022)